Tianfeng TF-7M cGMP-Compliant Production-Scale Freeze Dryer

Overview

The Tianfeng TF-7M is a fully integrated, cGMP-compliant production-scale freeze dryer engineered for reproducible, scalable lyophilization of pharmaceuticals, biologics, and high-value natural products. It operates on the fundamental principle of sublimation—removing water from frozen materials under deep vacuum while maintaining structural integrity and bioactivity. Unlike laboratory or pilot-scale units, the TF-7M is designed for continuous batch processing in regulated manufacturing environments. Its stainless steel chamber (AISI 304), rectangular shelf configuration (7+1 shelves), and 7.56 m² total shelf area support up to 100 kg of product per cycle—enabling efficient transition from clinical trial material to commercial supply. The system employs low-viscosity silicone oil as the heat transfer medium across all shelves, ensuring precise, uniform thermal control during freezing, primary drying, and secondary drying phases. Vacuum performance is maintained at ≤1.0 Pa via a dual-stage oil-sealed rotary vane pump and a −75 °C condenser with 100 kg/batch ice capacity—critical for achieving complete moisture removal in thermolabile formulations.

Key Features

• Shelf-based architecture with 7 active shelves (1200 × 900 × 20 mm each) and one additional shelf for temperature mapping or monitoring—total lyophilization area: 7.56 m²
• Shelf temperature range from −55 °C to +70 °C, with uniformity of ±1 °C during thermal soak (empty load), validated per ISO 13485 and EU Annex 1 requirements
• Integrated pre-freezing capability within the main chamber—eliminates need for external ultra-low temperature freezers and reduces contamination risk
• Full AISI 304 stainless steel construction with electropolished internal surfaces, zero-dead-leg welds, and radiused internal corners to meet cGMP cleanability standards
• OMRON PLC-based control system with HMI interface, supporting recipe management, real-time data logging, alarm history, and audit trail generation compliant with FDA 21 CFR Part 11
• Robust thermal insulation using aluminum silicate and polyisocyanurate foam—minimizes energy loss and improves process stability during long-duration cycles
• Modular design allows for seamless integration into existing utility infrastructure (compressed air, cooling water, electrical supply) and supports future scalability

Sample Compatibility & Compliance

The TF-7M accommodates a broad spectrum of lyophilizable matrices including aqueous pharmaceutical solutions (e.g., monoclonal antibodies, recombinant proteins, live attenuated vaccines), herbal extracts (e.g., sea cucumber, ginseng, cordyceps), and tissue-derived biomaterials (e.g., dermal grafts, corneal epithelium). All wetted parts comply with USP Class VI and EP 3.1.9 extractables/leachables guidelines. The system conforms to ISO 9001:2015 quality management standards and is manufactured under documented cGMP practices aligned with ICH Q5C, Q5D, and EU Annex 1. Full 3Q documentation (IQ/OQ/PQ) is available upon request—including sensor calibration certificates (PT100 shelf sensors traceable to NIST), vacuum leak rate validation (<0.01 mbar·L/s), and thermal mapping reports (per ASTM F2697-18). The unit supports automated sterilization-in-place (SIP) protocols when interfaced with compatible steam generators.

Software & Data Management

Control and data acquisition are managed through a validated Windows-based SCADA platform running on an industrial Lenovo PC. The software enables full-cycle automation—including ramp-and-soak freezing, pressure-controlled primary drying (manometric temperature measurement optional), and desorption endpoint detection via capacitance manometry or product temperature trending. All operational parameters (shelf temp, chamber pressure, condenser temp, vacuum pump status, valve positions) are logged at user-defined intervals (default: 10 s) with timestamped, tamper-evident records. Electronic signatures, role-based access control, and 21 CFR Part 11-compliant audit trails ensure regulatory readiness. Raw data exports to CSV or PDF formats; trend analysis tools support continuous process verification (CPV) per ICH Q8(R2) and Q9 frameworks.

Applications

The TF-7M serves critical roles across multiple regulated sectors: In pharmaceutical manufacturing, it supports lyophilization of injectables (lyo vials, cartridges, syringes), plasma-derived therapeutics, and cell/gene therapy intermediates. In traditional medicine, it preserves bioactive constituents of marine and botanical materials—such as sea cucumber saponins, ginsenosides, and polysaccharide-rich fungal extracts—without thermal degradation. In biobanking and regenerative medicine, it enables long-term stabilization of stem cells, decellularized tissues, and extracellular matrix scaffolds. Additional applications include R&D scale-up studies, stability testing per ICH Q1A–Q1E, and contract manufacturing for Phase III and commercial batches requiring full regulatory submission support.

FAQ

What regulatory standards does the TF-7M meet?

It complies with ISO 9001:2015, EU GMP Annex 1 (2022), ICH Q5C/Q5D, and is 21 CFR Part 11 ready. Full 3Q documentation and validation support packages are provided.
Can the system be qualified for sterile manufacturing?

Yes—the chamber and condenser are SIP-capable when connected to validated steam supply; HEPA-filtered nitrogen purge options are available for aseptic loading/unloading.
Is remote monitoring supported?

Standard Ethernet/IP communication enables integration with MES/SCADA systems; optional cloud-based dashboard provides real-time KPIs and alarm notifications.
What maintenance intervals are recommended?

Vacuum pump oil change every 2,000 operating hours; condenser defrost cycle after each batch; annual calibration of all PT100 sensors and pressure transducers per ISO/IEC 17025.
Does the system support cycle development and optimization?

Yes—programmable shelf ramps, pressure modulation, and real-time product temperature monitoring (via optional thermocouples) enable DOE-driven process characterization per ICH Q5C.